Skip to content

Comparison of efficacy and safety of Tramadol, Paroxetine and placebo in treatment of life long premature ejaculation

Comparison of efficacy and safety of Tramadol, Paroxetine and placebo in patients with life long premature ejaculation

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201008304582N2
Enrollment
150
Registered
2014-10-04
Start date
2013-06-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature ejaculation. Premature ejaculation

Interventions

Intervention 1: Tramadol 50 mg, 3 to 4 hours before the intervention (on demand) for 12 weeks. Intervention 2: Paroxetine 20 mg, 3 to 4 hours before the intervention (on demand) for 12 weeks. Interven
Treatment - Drugs
Placebo
Tramadol 50 mg, 3 to 4 hours before the intervention (on demand) for 12 weeks
Paroxetine 20 mg, 3 to 4 hours before the intervention (on demand) for 12 weeks
Placebo, 3 to 4 hours before the intervention (on demand) for 12 weeks

Sponsors

Urology Research Centre
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: at least one year of their marriage is past; to be between 18-50 years of age; have the possibility of intercourse at least once a week, ability to read and write Exclusion criteria: People who have a history of mental diseases, a physical illness such as diabetes and liver disease, alcohol or drug abuse, a history of surgery that has been effective on sexual function; history of endocrine disease, prostatitis; history of paroxetine and tramadol during the last 3 months

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Intravaginal ejaculation latency time (IELT). Timepoint: Baseline and 3 months after treatment. Method of measurement: Ask the patient based on the PEP Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Reza Motiei

Urology Research Center

urc1384@yahoo.com+98 13 1552 5259

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026